靶向头颈部鳞状细胞癌中的葡萄糖-胰岛素联系可诱导细胞毒性氧化应激并抑制肿瘤生长。

Targeting the Glucose-Insulin Link in Head and Neck Squamous Cell Carcinoma Induces Cytotoxic Oxidative Stress and Inhibits Cancer Growth.

作者信息

Mazambani Simbarashe, Park Seong-Ho, Choe Joshua H, Nguyen An H, Lee Bok-Soon, Jeong Ji Yun, Lee Shin Yup, Kim Chul-Ho, Park Yea-In, Padilla Joselyn, Lee Jiyoung, Thotala Dinesh, Oh Tae Gyu, Singh Pankaj K, Hur Hoon, Hur Junho K, Kim Jung-Whan, Kim Tae Hoon

机构信息

Department of Biological Sciences, The University of Texas at Dallas, Richardson, Texas.

Department of Oncology Science, The University of Oklahoma College of Medicine, Stephenson Cancer Center, Oklahoma City, Oklahoma.

出版信息

Cancer Res Commun. 2025 Jun 1;5(6):921-938. doi: 10.1158/2767-9764.CRC-23-0506.

Abstract

UNLABELLED

Head and neck squamous cell carcinoma (HNSCC) remains a clinically challenging malignancy with limited targeted therapy options and poor patient outcomes. Thus, identifying unique dependencies, including HNSCC-specific metabolic reprogramming, is imperative for improving treatment strategies for this disease. In this study, we show that HNSCC relies on elevated glucose transporter 1 (GLUT1)-mediated glucose uptake to support redox homeostasis and tumor growth. Analyses of GLUT1 expression data in tumors and cancer cell lines reveal significant upregulation of GLUT1 in HNSCC relative to both normal tissue and other cancer subtypes and that high GLUT1 expression correlates with poorer clinical outcomes. Using a basal epithelial layer-specific GLUT1-knockout mouse model, we demonstrate that GLUT1 ablation in HNSCC cells of origin markedly attenuates tumor initiation and progression, implicating the necessity of GLUT1 in HNSCC tumorigenesis. Building on this observation, combining pharmacologic inhibition of GLUT1 with pro-oxidants such as vitamin C and auranofin induces potent cytotoxicity in vitro and in vivo, partly by precipitating oxidative stress. We further observe that insulin signaling is required to sustain glucose uptake and redox homeostasis, as insulin receptor knockdown decreases proliferation and increases reactive oxygen species levels. Together, these results suggest that although GLUT1 overexpression is a key driver of glucose uptake, insulin signaling also contributes to the metabolic and oncogenic pathways underlying HNSCC progression. Consequently, strategies that co-target GLUT1 and insulin signaling to restrict glucose flux may synergize with pro-oxidant therapies, offering a promising therapeutic avenue for HNSCC.

SIGNIFICANCE

Enhanced GLUT1 expression and oncogenic insulin signaling drive elevated glucose uptake in HNSCC, which contribute to the maintenance of redox homeostasis and tumor growth. Disrupting both glucose uptake and redox balance may offer a promising therapeutic approach.

摘要

未标记

头颈部鳞状细胞癌(HNSCC)仍然是一种临床上具有挑战性的恶性肿瘤,靶向治疗选择有限,患者预后较差。因此,确定独特的依赖性,包括HNSCC特异性的代谢重编程,对于改善该疾病的治疗策略至关重要。在本研究中,我们表明HNSCC依赖于葡萄糖转运蛋白1(GLUT1)介导的葡萄糖摄取增加来维持氧化还原稳态和肿瘤生长。对肿瘤和癌细胞系中GLUT1表达数据的分析显示,相对于正常组织和其他癌症亚型,HNSCC中GLUT1显著上调,并且高GLUT1表达与较差的临床结果相关。使用基底上皮层特异性GLUT1敲除小鼠模型,我们证明起源于HNSCC细胞中的GLUT1缺失显著减弱肿瘤起始和进展,这表明GLUT1在HNSCC肿瘤发生中是必需的。基于这一观察结果,将GLUT1的药理抑制与维生素C和金诺芬等促氧化剂联合使用,在体外和体内均诱导了强大的细胞毒性,部分是通过引发氧化应激。我们进一步观察到胰岛素信号传导是维持葡萄糖摄取和氧化还原稳态所必需的,因为胰岛素受体敲低会降低增殖并增加活性氧水平。总之,这些结果表明,虽然GLUT1过表达是葡萄糖摄取的关键驱动因素,但胰岛素信号传导也有助于HNSCC进展的代谢和致癌途径。因此,共同靶向GLUT1和胰岛素信号传导以限制葡萄糖通量的策略可能与促氧化剂疗法协同作用,为HNSCC提供一种有前景的治疗途径。

意义

增强的GLUT1表达和致癌胰岛素信号传导驱动HNSCC中葡萄糖摄取增加,这有助于维持氧化还原稳态和肿瘤生长。破坏葡萄糖摄取和氧化还原平衡可能提供一种有前景的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b218/12141995/a3ca5134c6a3/crc-23-0506_f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索